Table 1_Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review.docx

Table 1_Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review.docx

<p>Primary pulmonary choriocarcinoma (PPC) is an extremely rare malignant cancer in men with no clinical guidelines for the treatment. Cytotoxic chemotherapy has a limited effect on the prognosis of PPC. Recently, immune checkpoint inhibitors (ICIs) have shown promising treatment effectiveness...

Full description

Saved in:
Bibliographic Details
Main Author: Xiaojing Liang (475311) (author)
Other Authors: Guoqing Xu (349989) (author), Jisong Zhang (1652344) (author), Li Xu (108702) (author), Liangliang Dong (736528) (author), Xiaoyue Wang (212345) (author), Weidong Han (102395) (author), Enguo Chen (5258471) (author)
Published: 2025
Subjects:
Genetic Immunology
primary pulmonary choriocarcinoma
chemotherapy
immune checkpoint inhibitors
programmed death-ligand 1
human chorionic gonadotropin
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items